Finance

Lists
PBV:FRA
Prestige Consumer Healthcare Inc
€ ३९.४०
-१.०१%
(-०.४०) 1D
अक्टोबर २, ०८:२७:१३ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PBV...
Open
€ ३९.४०
High
€ ३९.४०
Low
€ ३९.४०
Mkt. cap
२.१२ अरब
Avg. vol.
०.००
Volume
०.००
52-wk high
€ ६०.००
52-wk low
€ ३८.००
No. of employees
८९०
Open
€ ३९.४०
High
€ ३९.४०
Low
€ ३९.४०
Mkt. cap
२.१२ अरब
Avg. vol.
०.००
Volume
०.००
52-wk high
€ ६०.००
52-wk low
€ ३८.००
No. of employees
८९०
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
१० मिनेट पहिले
DLocal (DLO) Expands Payment Options, Is It Still 73% Undervalued?
MarketBeat
MarketBeat
·
३९ मिनेट पहिले
Biodesix, Inc. (NASDAQ:BDSX) Stock Has Average Target Price of $35.00
Seeking Alpha
Seeking Alpha
·
१ घण्टा पहिले
Inside The September 2026 S&P 500 Momentum Index Reconstitution
Profile
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia. Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano. The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015. Wikipedia
About Prestige Consumer Healthcare Inc
CEOMatthew M. Mannelly
Employees८९०
Founded१९९६
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२७.४१ करोड
२८.३४ करोड
२८.१६ करोड
२६.५७ करोड
Cost of goods sold
१२.०० करोड
१२.३६ करोड
१३.२४ करोड
१२.३६ करोड
Cost of revenue
१२.०० करोड
१२.३६ करोड
१३.२४ करोड
१२.३६ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.६७ करोड
६.९७ करोड
६.५४ करोड
७.८० करोड
Operating expense
७.४४ करोड
७.७३ करोड
७.३७ करोड
८.६७ करोड
Total operating expenses
१९.४४ करोड
२०.१० करोड
२०.६१ करोड
२१.०४ करोड
Operating income
७.९७ करोड
८.२५ करोड
७.५५ करोड
५.५४ करोड
Other non operating income
-५.०१ लाख
-१.०० करोड
७.०८ लाख
-३४.०० हजार
EBT including unusual items
६.९१ करोड
६.१८ करोड
६.४८ करोड
३.८५ करोड
EBT excluding unusual items
६.९१ करोड
६.१८ करोड
६.४८ करोड
४.१४ करोड
Income tax expense
२.६९ करोड
१.५१ करोड
१.०८ करोड
९३.६४ लाख
Effective tax rate
३८.९४%
२४.४६%
१६.७४%
२४.३०%
Other operating expenses
-
-
-
-
Net income
४.२२ करोड
४.६७ करोड
५.३९ करोड
२.९२ करोड
Net profit margin
१५.४०%
१६.४७%
१९.१५%
१०.९८%
Earnings per share
०.८६
१.१४
१.२३
०.९८
Interest and investment income
-
-
-
-
Interest expense
-१.०० करोड
-१.०७ करोड
-१.१४ करोड
-१.३९ करोड
Net interest expenses
-१.०० करोड
-१.०७ करोड
-१.१४ करोड
-१.३९ करोड
Depreciation and amortization charges
७६.६३ लाख
७५.९२ लाख
८३.५२ लाख
८७.५३ लाख
EBITDA
८.७३ करोड
९.०१ करोड
८.३८ करोड
६.४१ करोड
Gain or loss from assets sale
१.३१ लाख
९.०० हजार
२५.०० हजार
१.९१ लाख
AI content may include mistakes. Learn more
Google एपहरू